Literature DB >> 31870304

Correction to: Procalcitonin-guided antibiotic therapy in critically ill adults: a meta-analysis.

Tao Zhang1, Yan Wang1, Qianting Yang1, Yalin Dong2.   

Abstract

After publication of the original article [1], the authors have reported that the software developers had used a new amended version of the software called "v0.9.5.10" instead of "v0.9.5.5", which is referred to in the original article.

Entities:  

Year:  2019        PMID: 31870304      PMCID: PMC6927184          DOI: 10.1186/s12879-019-4707-7

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


Correction to: BMC Infect Dis https://doi.org/10.1186/s12879-017-2622-3 After publication of the original article [1], the authors have reported that the software developers had used a new amended version of the software called “v0.9.5.10” instead of “v0.9.5.5”, which is referred to in the original article. Thus, the authors have conducted trial sequential analysis with new version of the software for the two continuous end-points. All corrections are following: 1. “v0.9.5.5” in the Trial sequential analysis (methods section) is corrected to “v0.9.5.10”. 2. The estimated required information size of Length of hospitalization (7161, results section) is corrected to “7242”. 3. Fig. 5 is below updated.
Fig. 5

Effects of PCT-guided antibiotics therapy on ICU patients for the length of hospitalization. a Forest plots; b Trial sequential analysis

Effects of PCT-guided antibiotics therapy on ICU patients for the length of hospitalization. a Forest plots; b Trial sequential analysis The conclusions are as same as published in the original article. [1] References: Zhang et al. BMC Infectious Diseases (2017) 17:514, DOI: 10.1186/s12879-017-2622-3
  1 in total

1.  Procalcitonin-guided antibiotic therapy in critically ill adults: a meta-analysis.

Authors:  Tao Zhang; Yan Wang; Qianting Yang; Yalin Dong
Journal:  BMC Infect Dis       Date:  2017-07-24       Impact factor: 3.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.